Correlation Between Royal Caribbean and Vertex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Royal Caribbean and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Royal Caribbean and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Royal Caribbean Group and Vertex Pharmaceuticals, you can compare the effects of market volatilities on Royal Caribbean and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Royal Caribbean with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Royal Caribbean and Vertex Pharmaceuticals.
Diversification Opportunities for Royal Caribbean and Vertex Pharmaceuticals
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Royal and Vertex is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Royal Caribbean Group and Vertex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and Royal Caribbean is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Royal Caribbean Group are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of Royal Caribbean i.e., Royal Caribbean and Vertex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Royal Caribbean and Vertex Pharmaceuticals
Assuming the 90 days trading horizon Royal Caribbean Group is expected to generate 1.15 times more return on investment than Vertex Pharmaceuticals. However, Royal Caribbean is 1.15 times more volatile than Vertex Pharmaceuticals. It trades about 0.13 of its potential returns per unit of risk. Vertex Pharmaceuticals is currently generating about 0.06 per unit of risk. If you would invest 218,266 in Royal Caribbean Group on November 26, 2024 and sell it today you would earn a total of 258,684 from holding Royal Caribbean Group or generate 118.52% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Royal Caribbean Group vs. Vertex Pharmaceuticals
Performance |
Timeline |
Royal Caribbean Group |
Vertex Pharmaceuticals |
Royal Caribbean and Vertex Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Royal Caribbean and Vertex Pharmaceuticals
The main advantage of trading using opposite Royal Caribbean and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Royal Caribbean position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.Royal Caribbean vs. Deutsche Bank Aktiengesellschaft | ||
Royal Caribbean vs. Delta Air Lines | ||
Royal Caribbean vs. Capital One Financial | ||
Royal Caribbean vs. Air Transport Services |
Vertex Pharmaceuticals vs. The Home Depot | ||
Vertex Pharmaceuticals vs. Grupo Sports World | ||
Vertex Pharmaceuticals vs. First Majestic Silver | ||
Vertex Pharmaceuticals vs. UnitedHealth Group Incorporated |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
CEOs Directory Screen CEOs from public companies around the world | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |